Jun 11, 2025, 08:22
Mastering the Art of Platelet Transfusion: Dr. Akhil Breaks Down the Clinical Thresholds You Need to Know
In a recent insightful post on X, Dr. Akhil delivers a concise yet powerful breakdown of platelet transfusion thresholds—a critical guide for clinicians navigating invasive procedures in patients with thrombocytopenia.
“When will you want to transfuse platelets?
Typical Recommended Platelet Count Thresholds for Common Procedures
Platelet transfusion may be considered when the patient’s platelet count is below the threshold for the corresponding procedure.
Neurosurgery or ocular surgery – <100,000/microL
Most other major surgery – <50,000/microL
Endoscopic procedures – <50,000/microL for therapeutic procedures; 20,000/microL for low risk diagnostic procedures
Bronchoscopy with bronchoalveolar lavage (BAL) – <20,000 to 30,000/microL
Central line placement – <20,000/microL
Lumbar puncture – <10,000 to 20,000/microL in patients with hematologic malignancies and <40,000 to 50,000 in patients without hematologic malignancies; lower thresholds may be used in patients with immune thrombocytopenia (ITP)
Neuraxial analgesia/anesthesia – <80,000/microL
Bone marrow aspiration/biopsy – <20,000/microL
Actively bleeding patients with thrombocytopenia should be transfused with platelets immediately to keep platelet counts >50,000/microL in most bleeding situations including disseminated intravascular coagulation (DIC), and >100,000/microL if there is central nervous system bleeding
Source : UpToDate”
Remember: Actively bleeding patients require immediate transfusion. Timely action can be lifesaving, especially in cases of CNS bleeding or DIC.”
See the full breakdown and expert commentary now on Hemostasis Today.
-
Jul 28, 2025, 12:26ISTH Pulse Picks: Top Episodes You Can’t Miss
-
Jul 27, 2025, 06:41Clot Classroom: Meaningful Insights into Renal Vein Thrombosis Awareness
-
Jul 27, 2025, 06:04Unlocking Hematology: Dr. Houssein Safa’s Game-Changing Educational Series for Internists
-
Jul 26, 2025, 18:32From Jawless Fish to Mammals: Clotting Cascade Origins
-
Jul 26, 2025, 15:12ISTH 2025 Guidelines: Submit Your Topic Proposals by September 8
-
Jul 28, 2025, 15:18Investigational Therapies for VWD and Glanzmann Thrombasthenia Unveiled at ISTH 2025: 2 Promising Paths Forward
-
Jul 28, 2025, 12:19World Hepatitis Day: Prioritizing Liver Health in Bleeding Disorders
-
Jul 28, 2025, 12:04ChAdOx1 and Shear‑Dependent Platelet Aggregation: Uncovering a New Thrombotic Pathway
-
Jul 27, 2025, 16:22WSO Global Stroke Fact Sheet 2025: A Sobering Reminder
-
Jul 27, 2025, 12:14Villalta Score in Review: Improving PTS Assessment Through Clinical Criteria
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 28, 2025, 12:53Zambia’s Hemophilia Prophylaxis Success
-
Jul 26, 2025, 16:14Cesar Garrido: Forging Strong Partnerships on WHA78 ''Global Health Equity'' Event
-
Jul 23, 2025, 15:34Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
-
Jul 23, 2025, 11:05Haemnet Gives Voice to Parents Facing the Challenges of Childhood Bleeding Disorders
-
Jul 23, 2025, 10:43From Blood Clot Survivor to NFL History: Trey Smith’s Record Deal
Jul 28, 2025, 14:55
Jul 28, 2025, 13:42
Jul 28, 2025, 13:18
Jul 28, 2025, 12:53
Jul 28, 2025, 12:26
Jul 28, 2025, 12:19
Jul 27, 2025, 16:22